Product Information
DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $0.4952 per EA under NDC 00228306411. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 22, 2012. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 25 MG CAP
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfateStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228306411
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA077302FDA Approved
6/22/2012
TE Code
AB1
On Market Since
6/22/2012
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4952 per EA |
|---|---|
| All-time high | $4.0352 (Jun 11, 2014) |
| All-time low | $0.4173 (May 22, 2024) |
| 52-week high | $0.5709 |
| 52-week low | $0.4896 |
| Median price | $1.0469 |
| Average price | $1.7032 |
| Largest weekly change | -47.3% (Apr 22, 2020) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Actavis Pharma, Inc., is $0.4952 per EA (NDC 00228306411), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 87.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?
Since Nov 28, 2013, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $4.0352 (Jun 11, 2014), with a median of $1.0469 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 25 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?
DEXTROAMP-AMPHET ER 25 MG CAP (NDC 00228306411) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.